Surge in Personalized Medicine
In recent years, there's been a swift increase in the adoption of personalized medicine approaches, specifically in the field of oncology. This is because personalized medicine facilitates the development of targeted therapies, allowing providers to offer individual treatment plans based on a patient's unique genetic makeup. Genetic testing is the foundation of this approach, used to diagnose specific conditions, guide treatment decisions, and even assess patients' risks of developing certain diseases. As an instance, BRCA1 and BRCA2 mutation testing guide the clinician's decision for prostate cancer treatment, thereby personalized therapy design results in better patient outcomes. Therefore, the demand surge in personalized medicine is driving the genetic testing market globally.
